Vistagen Therapeutics Inc (VTGN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 03/31
| 12-2024 | 09-2024 | 06-2024 | 03-2024 | 12-2023 | |
| Sales | 234 | 183 | 84 | 198 | 411 |
| Gross Profit | 234 | 183 | 84 | 198 | 411 |
| Operating Expenses | 15,354 | 14,410 | 12,215 | 11,557 | 8,295 |
| Operating Income | -15,120 | -14,227 | -12,131 | -11,359 | -7,884 |
| Other Income | 1,031 | 1,273 | 1,398 | 1,839 | 1,534 |
| Pre-tax Income | -14,089 | -12,954 | -10,733 | -9,520 | -6,350 |
| Income Tax | N/A | 7 | N/A | -7 | N/A |
| Net Income Continuous | -14,089 | -12,961 | -10,733 | -9,513 | -6,350 |
| Net Income | $-14,089 | $-12,961 | $-10,733 | $-9,521 | $-6,350 |
| EPS Basic Total Ops | -0.46 | -0.42 | -0.35 | 0.30 | -0.22 |
| EPS Basic Continuous Ops | -0.46 | -0.42 | -0.35 | 0.30 | -0.22 |
| EPS Diluted Total Ops | -0.46 | -0.42 | -0.35 | 0.30 | -0.22 |
| EPS Diluted Continuous Ops | -0.46 | -0.42 | -0.35 | 0.30 | -0.22 |
| EPS Diluted Before Non-Recurring Items | -0.46 | -0.42 | -0.35 | -0.25 | N/A |
| EBITDA(a) | $-15,183 | $-14,330 | $-12,116 | $-11,326 | $-7,853 |